RecruitingNCT04144439
Study of GABA for ADHD symptoms and seizures in children with epilepsy
About this title
Read the official source — NCT04144439Medication studyAges 4–18Egypt
Understand this study
Who could participate?
Listed age limits: 4 years to 18 years.
- Listed locations
- TantaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 1, 2018
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 30
- Sponsor
- Sherief Abd-Elsalam
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Egypt
- Age range
- From 4 Years to 18 Years
- Official registry ID
- NCT04144439
- Official title
Show the full official title
Effect of Gamma Aminobutyric Acid on ADHD and Seizures in Children With Epilepsy.
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Tanta
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Sherief Abd-Elsalam.
Does this study involve medication?
Yes. The study involves medication, including GABA.
Who can participate?
Listed age limits: 4 years to 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
